Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01831713 · ClinicalTrials.gov registry record
Pulmonary Blood Flow Measurements in CHF Patients
A clinical trial, sponsored by Echosense.
- Terminated
- Registry status
- 200
- Enrollment target
NCT01831713 is a clinical trial that was terminated before completion, run by Echosense. The registered enrollment target is 200 participants.
The verdict
NCT01831713 was terminated before completion, sponsored by Echosense.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
Historically, transthoracic Doppler echocardiography has been unable to provide interpretable data of blood flow within the lung parenchyma because of air attenuation of Doppler signals. Recently, a transthoracic Doppler system known as the Sonara/tek Transcranial Doppler (TCD) System has been developed that can identify parenchymal pulmonary blood flow (PPBF) signals. The ability to non-invasively collect information regarding the pulmonary aspect of the cardio-pulmonary system may provide valuable information and new insights into the structural and functional characteristics of the lung parenchyma and vasculature in health and disease states.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2012-09 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01831713
The ClinicalTrials.gov registry entry for NCT01831713 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Echosense, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01831713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01831713 about?
NCT01831713 is a clinical study titled "Pulmonary Blood Flow Measurements in CHF Patients". Historically, transthoracic Doppler echocardiography has been unable to provide interpretable data of blood flow within the lung parenchyma because of air attenuation of Doppler signals. Recently, a transthoracic Doppler system known as the Sonara/tek Transcranial Doppler (TCD) System has been devel...
What is the current status of trial NCT01831713?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2012-09. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT01831713?
This trial is sponsored by Echosense, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.